Study Finds Ozempic May Reduce Stroke and Alzheimer's Risk by 49%
A recent study suggests that Ozempic, a GLP-1 drug used for weight loss, may reduce the risk of stroke and Alzheimer's disease by up to 49%. This finding highlights the potential protective effects of GLP-1 medications beyond their primary use. The research opens new avenues for dementia prevention and stroke risk management.
Times Now·


